Flagship and Moderna, which are headquartered near each other in Cambridge, Mass., continue to share ties. Flagship CEO Noubar Afeyan serves as chairman of Moderna; Stéphane Bancel, Moderna’s CEO, serves as a Flagship special partner. Flagship also holds 20 million shares of Moderna stock, which are currently valued at more than $4 billion after the vaccine-maker’s stock price soared during the pandemic; it sold $1.4 billion worth of Moderna shares earlier this year, senior partner Christine Heenan confirmed. Moderna had never turned a profit before the pandemic.
View original article here Source